Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Soleno Therapeutics Inc
About SLNO
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its first commercial product, VYKAT XR (diazoxide choline) extended-release tablets, is a once-daily oral treatment for hyperphagia in adults and children four years of age and older with Prader-Willi syndrome (PWS). VYKAT XR contains diazoxide choline, a potent ATP-sensitive potassium (KATP) channel activator. The KATP channels play a central role in the regulation of a number of physiological processes which may otherwise be dysregulated, contributing to the pathophysiology of several diseases. In the context of the underlying genetic or structural defects in PWS, these pathophysiological processes may cumulatively contribute to increases in appetite and aggressive food seeking, lack of satiety, accumulation of excess body fat and the establishment and perpetuation of the obese state. PWS is a rare, complex genetic neurobehavioral/metabolic disorder.
Find out what a historical investment in Soleno Therapeutics Inc would be worth today using our SLNO stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy SLNO shares in Australia?
Buying SLNO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Soleno Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SLNO
What is the ticker symbol of Soleno Therapeutics Inc?
The ticker symbol for Soleno Therapeutics Inc is SLNO.
How much is one share of SLNO?
One share of SLNO is valued at $53.00 as of 07 June 2026.
What is the market capitalisation of Soleno Therapeutics Inc SLNO?
As of 07 June 2026 Soleno Therapeutics Inc has a market cap of -.
What is the 52-week high for Soleno Therapeutics Inc stock?
The Soleno Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Soleno Therapeutics Inc stock?
The Soleno Therapeutics Inc 52-week low stock price is $NaN.
Can I buy SLNO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SLNO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SLNO on Stake
- Buy SLNO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SLNO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SLNO related stocks